Angiotensin-Converting Enzyme-1 (ACE1) has been suggested to play a direct role in regulating the degradation of Aβ, a recent cross-sectional regression analysis concluded that ACE protein level and CSF activity were significantly lower in subjects with AD therefore strengthening the hypothesis that ACE degrades Aβ [21]. Here, ACE is linked to Alzheimer disease.